Branka Grubor-Bauk

Dr Branka Grubor-Bauk

Senior Research Officer

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Dr Grubor-Bauk is a viral immunologist  focusing on the development of novel vaccines. For the past 9 years she has worked in vaccine development focusing on the prevention of hepatitis C virus (HCV), human immunodeficiency virus (HIV) and Zika virus. Her research included investigating various vaccine platforms, strategies and improved deliveries for DNA, and viral vector vaccines with a strong focus on research translation. She received her PhD from the Department of Microbiology and Immunology at the University of Adelaide where her research focused on the role of NKT cells in immunopathogenesis of herpes simplex virus. Her findings were seminal in discovering a role for NKT cells in viral infections.  After her PhD, she spent 3 years working in the biotechnology sector to gain industry experience that serves as the platform for her academic career. She is focused on translational research with an emphasis on developing commercial research partnerships that lead to solutions with clinical application.

Student projects

Virology Laboratory has student projects available for Honours, Masters and PhD studies. The chosen project will cover vaccine development in the areas of Zika virus, hepatitis C and HIV, with options for industry collaborations.

Prospective students can contact me directly via email with any further questions. 

  • Language Competencies

    Language Competency
  • Education

    Date Institution name Country Title
    2007 University of Adelaide, Adelaide Australia PhD
    1999 University of Adelaide, Adelaide Australia Bachelor of Health Sciences (Honours)
    1998 University of Adelaide, Adelaide Australia Bachelor of Science

2019             B Grubor-Bauk, EJ Gowans, DK Wijesundara ($200,000) "A novel Zika virus DNA vaccine that provides complete protection from infection." Commercial Accelerator Scheme, Adelaide Enterprise, University of Adelaide and The Hospital Research Foundation

2019             B Grubor-Bauk "Barbara Kidman Women's Fellowship" ($60,000). University of Adelaide and The Hospital Research Foundation

2019             DK Wijesundara, EJ Gowans, S Robertson, B Grubor-Bauk, A Shrestha "A pre-clinical evaluation of an innovative DNA-based vaccination regimen to protect women of childbearing age against Zika virus during sexual transmission." Ch7 Children's Research Foundation and The Hospital Research Foundation ($200,000)

2018               Z Kopecki, B Grubor-Bauk, KA Fenix, D Wijesundara, A Cowin ($28,619) "Identification of a diagnostic marker for assessment and management  of psoriasis. New Adventures Fund UniSA and The Hospital Research Foundation 

2018                 EJ Gowans, B Grubor-Bauk, D Wijesundara, N Eyre ($88,000)  "HCV challenge studies in vaccinated mice’ . Australian Centre for HIV and Hepatitis Virology Research (ACH2).

2016-2018        EJ Gowans, B Grubor-Bauk, D Wijesundara. ($293,880):  A DNA vaccine for Zika virus. National Foundation for Medical Research and  Innovation (NFMRI)

2017                 EJ Gowans, B Grubor-Bauk, D Wijesundara ($85,000) A multigenotypic HCV DNA Vaccine. Australian Centre for HIV and Hepatitis Virology Research (ACH2)

2016-2017        EJ Gowans, B Grubor-Bauk, D Wijesundara ($100,000) "A DNA vaccine to induce protective neutralizing antibodies to the HIV Tat protein." The Hospital Research Foundation

2014                EJ Gowans, B Grubor-Bauk ($100,000) "Optimisation of HCV vaccine design."  The Hospital Research Foundation .

2014-2015        EJ Gowans, I Roberts-Thomson, B Grubor-Bauk ($300, 000). “DNA vaccine therapy for HCV.” The Hospital Research Foundation .

2012-2013        E.J. Gowans and B Grubor-Bauk 2012/2013 ($174,000) “Development of a cytolytic HCV vaccine and a novel challenge model to test efficacy.”  Australian Centre for HIV and Hepatitis Virology Research (ACH2).

  • Past Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2015 - 2019 Co-Supervisor Pre-Clinical Evaluation of a Vaccination Strategy to Induce Liver Resident Memory T Cells against Hepatitis C Virus Doctor of Philosophy Doctorate Full Time Mr Zelalem Addis Mekonnen
    2015 - 2016 Co-Supervisor Strategies for the development of recombinant porcine adenovirus-based vaccines against Hepatitis C virus. Master of Philosophy (Medical Science) Master Full Time Mr Harshwardhan Jagdale
    2014 - 2018 Co-Supervisor Novel DNA Vaccine Formulations Against Hepatitis C Virus Doctor of Philosophy Doctorate Full Time Dr Makutiro Ghislain Masavuli
    2013 - 2016 Co-Supervisor Novel Recombinant DNA and Live Virus Vaccines to Prevent or Control HIV-1 Infection Doctor of Philosophy Doctorate Full Time Mr Khamis Tomusange
    2012 - 2014 Co-Supervisor Evaluating the Immuno-modulatory Effects of a Natural Adjuvant as a Novel Vaccine Strategy Doctor of Philosophy Doctorate Full Time Miss Tamsin Jade Garrod
    2012 - 2013 Co-Supervisor Optimising DNA vaccine technology to prevent HIV-1 Infection Doctor of Philosophy Doctorate Full Time Miss Tessa Gargett
    2012 - 2017 Co-Supervisor The Development of a Multi-Antigenic Cytolytic DNA Vaccine against HCV Doctor of Philosophy Doctorate Full Time Dr Jason Anthony Gummow
    2010 - 2012 Co-Supervisor Suicide Genes in a Novel Vaccination Strategy for Hepatitis C Master of Philosophy Master Full Time Mr Hugh Francis Trahair
  • Position: Senior Research Officer
  • Phone: 82227368
  • Email:
  • Fax: 8222 7872
  • Campus: The Queen Elizabeth Hospital
  • Building: QEH- Basil Hetzel Institute, floor 1
  • Org Unit: Surgical Specialties

Connect With Me
External Profiles